Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report

November 2022 | 62 pages | ID: B320842F77FEN
MarketLine

Abstracts

Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report

SUMMARY

Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

KEY HIGHLIGHTS

Boehringer Ingelheim International GmbH (Boehringer or ‘the company) is a privately-held pharmaceuticals and animal health business group. The company offers a wide range of prescription medicines, biopharmaceutical products and animal healthcare products. It also conducts developments, research and manufacture of pharmaceuticals. Boehringer’s products find application in the treatment of respiratory diseases, central nervous system disorders, metabolic disorders, cardiovascular diseases, urological and viral conditions, cancer among others. It operates facilities for manufacturing pharmaceutical products, medical products, and chemical active substances. Boehringer operates in Europe, the Americas, Asia, Australia, and Africa. The company is headquartered in Ingelheim, Rheinland-Pfalz, Germany

SCOPE

• Detailed information on Boehringer Ingelheim GmbH required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Boehringer Ingelheim GmbH in the form of a SWOT analysis
• An in-depth view of the business model of Boehringer Ingelheim GmbH including a breakdown and examination of key business segments
• Intelligence on Boehringer Ingelheim GmbH's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Boehringer Ingelheim GmbH, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

REASONS TO BUY

• Gain understanding of Boehringer Ingelheim GmbH and the factors that influence its strategies.
• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Boehringer Ingelheim GmbH as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Boehringer Ingelheim GmbH's business structure, strategy and prospects.

Contents

Company Snapshot
Boehringer Ingelheim GmbH: Company Overview
Boehringer Ingelheim GmbH: Overview and Key Facts
Boehringer Ingelheim GmbH: Overview
Boehringer Ingelheim GmbH: Key Facts
Boehringer Ingelheim GmbH: Key Employees
Boehringer Ingelheim GmbH: Key Employee Biographies
Boehringer Ingelheim GmbH: Major Products and Services
Boehringer Ingelheim GmbH: Company History
Boehringer Ingelheim GmbH: Management Statement
Boehringer Ingelheim GmbH: Locations and Subsidiaries
Boehringer Ingelheim GmbH: Key Competitors
Boehringer Ingelheim GmbH: Company Analysis
Boehringer Ingelheim GmbH: Business Description
Boehringer Ingelheim GmbH: SWOT Analysis
Boehringer Ingelheim GmbH: SWOT Overview
Boehringer Ingelheim GmbH: Strengths
Boehringer Ingelheim GmbH: Weaknesses
Boehringer Ingelheim GmbH: Opportunities
Boehringer Ingelheim GmbH: Threats
Boehringer Ingelheim GmbH: Corporate Financial Deals Activity
Boehringer Ingelheim GmbH: Financial Deals Overview
Boehringer Ingelheim GmbH: Targets and Partners
Boehringer Ingelheim GmbH: Top Deals 2018 - 2022YTD*
Boehringer Ingelheim GmbH: Advisors
Boehringer Ingelheim GmbH: Top Legal Advisors
Boehringer Ingelheim GmbH: Top Financial Advisors
Boehringer Ingelheim GmbH: Mergers and Acquisitions
Boehringer Ingelheim GmbH: Corporate Venturing
Boehringer Ingelheim GmbH: Partnership
Boehringer Ingelheim GmbH: Divestments
Boehringer Ingelheim GmbH: Private Equity and Ownership
Boehringer Ingelheim GmbH: Recent Developments
Boehringer Ingelheim GmbH: News and Events Summary
Boehringer Ingelheim GmbH: Financial Deals
Boehringer Ingelheim GmbH: Financial Performance
Boehringer Ingelheim GmbH: Regulatory and Legal Events
Boehringer Ingelheim GmbH: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List Of Tables

LIST OF TABLES

Table 1: Boehringer Ingelheim GmbH: Key Facts
Table 2: Boehringer Ingelheim GmbH: Key Employees
Table 3: Boehringer Ingelheim GmbH: Company History
Table 4: Boehringer Ingelheim GmbH: Locations and Subsidiaries
Table 5: Boehringer Ingelheim GmbH: Key Competitors
Table 6: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Boehringer Ingelheim GmbH: M&A Activity by Geography (TTM*)
Table 8: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 9: Boehringer Ingelheim GmbH: M&A Average Deal Size - Value (US$m)
Table 10: Boehringer Ingelheim GmbH: Targets and Partners
Table 11: Boehringer Ingelheim GmbH: Top Deals 2018 - 2022YTD*
Table 12: Boehringer Ingelheim GmbH: Legal Advisor Ranking by Value (US$m)
Table 13: Boehringer Ingelheim GmbH: Financial Advisor Ranking by Value (US$m)
Table 14: Boehringer Ingelheim GmbH: M&A Volume and Value Trend (2018 - YTD*2022)
Table 15: Boehringer Ingelheim GmbH: M&A Activity by Geography (2018 - YTD*2022)
Table 16: Boehringer Ingelheim GmbH: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Table 17: Boehringer Ingelheim GmbH: Corporate Venturing by Geography (2018 - YTD*2022)
Table 18: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 19: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 20: Boehringer Ingelheim GmbH: Divestments Volume and Value Trend (2018 - YTD*2022)
Table 21: Boehringer Ingelheim GmbH: Divestments by Geography (2018 - YTD*2022)
Table 22: Boehringer Ingelheim GmbH: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022)
Table 23: Boehringer Ingelheim GmbH: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022)
Table 24: Boehringer Ingelheim GmbH: News and Events Summary
Table 25: Boehringer Ingelheim GmbH: Financial Deals
Table 26: Boehringer Ingelheim GmbH: Financial Performance
Table 27: Boehringer Ingelheim GmbH: Regulatory and Legal Events
Table 28: Boehringer Ingelheim GmbH: Research & Development

List Of Figures

LIST OF FIGURES

Figure 1: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Boehringer Ingelheim GmbH: M&A Activity by Geography (TTM*)
Figure 3: Boehringer Ingelheim GmbH: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 4: Boehringer Ingelheim GmbH: M&A Average Deal Size - Value (US$m)
Figure 5: Boehringer Ingelheim GmbH: M&A Volume and Value Trend (2018 - YTD*2022)
Figure 6: Boehringer Ingelheim GmbH: M&A Activity by Geography (2018 - YTD*2022)
Figure 7: Boehringer Ingelheim GmbH: Corporate Venturing Volume and Value Trend (2018 - YTD*2022)
Figure 8: Boehringer Ingelheim GmbH: Corporate Venturing by Geography (2018 - YTD*2022)
Figure 9: Boehringer Ingelheim GmbH: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 10: Boehringer Ingelheim GmbH: Partnership Trend by Deal Type (2018 - YTD*2022)
Figure 11: Boehringer Ingelheim GmbH: Divestments Volume and Value Trend (2018 - YTD*2022)
Figure 12: Boehringer Ingelheim GmbH: Divestments by Geography (2018 - YTD*2022)
Figure 13: Boehringer Ingelheim GmbH: Private Equity and Ownership Volume and Value Trend (2018 - YTD*2022)
Figure 14: Boehringer Ingelheim GmbH: Private Equity and Ownership Volume by Deal Type (2018 - YTD*2022)